In an adult male being evaluated for a testicular mass or infertility, how should I order a serum quantitative β‑human chorionic gonadotropin (β‑hCG) test?

How to Order Quantitative β-hCG in Adult Males

Order a serum quantitative β-human chorionic gonadotropin (β-hCG) test as part of a mandatory three-marker panel that includes AFP and LDH, drawn before any intervention in males with suspected testicular masses or infertility workup. 1, 2, 3

Ordering the Complete Marker Panel

Always order all three tumor markers together—never order β-hCG in isolation:

• Request serum AFP, β-hCG, and LDH simultaneously before orchiectomy or any other intervention in males with suspected germ cell tumors 1, 2, 3
• Specify "quantitative β-hCG" or "serum β-hCG" to ensure you receive numeric values rather than qualitative results 2
• Order these markers even if physical examination and ultrasound appear normal, as normal marker levels do not rule out testicular neoplasm 1

Critical Timing Considerations

• Draw blood before orchiectomy to establish baseline values that guide all subsequent treatment decisions 1, 2
• Repeat the panel after orchiectomy to assess for residual disease, using the half-life of β-hCG (1.5–3 days) to determine if levels are appropriately declining 2, 4
• If initial values are elevated, repeat testing to confirm elevation and allow precise staging before treatment 2

Assay Selection Matters

Be aware that not all β-hCG assays detect the same variants:

• Most automated commercial laboratory tests detect only regular hCG, which can miss hyperglycosylated hCG (the predominant form in early germ cell tumors and choriocarcinoma) 5
• The free β-subunit of hCG (hCGβ) is elevated in 40% of seminomas but may be missed by assays measuring only intact hCG 6
• Request an assay that detects all β-subunit variants if available (e.g., older-style hCGβ radioimmunoassay or Siemens Immulite platform), particularly for seminoma evaluation 5, 6

Interpretation Pitfalls to Avoid

Recognize common causes of false results:

• Hypogonadism from prior orchiectomy or chemotherapy can cause false β-hCG elevation; supplemental testosterone may reduce this 3
• Marijuana use can cause benign serum elevations of β-hCG that do not indicate malignancy 2
• Heterophilic antibodies can produce false-positive hCG results, particularly in assays that do not include blocking agents 1, 3
• Extremely high concentrations of hCG variants (hCGβ ≥240,000 pmol/L or hCGβcf ≥63,000 pmol/L) can paradoxically cause falsely decreased results in certain quantitative assays 7

Clinical Context for Ordering

In males with testicular mass:

• Order the three-marker panel (AFP, β-hCG, LDH) immediately upon identifying an intratesticular mass on ultrasound 2, 4

In males with extragonadal masses:

• Order the panel when evaluating retroperitoneal, mediastinal, or supraclavicular masses in young men, as these may represent extragonadal germ cell tumors 4, 3

In infertility evaluation:

• Order the panel if ultrasound reveals suspicious findings (hypoechoic mass, macrocalcification, or marked atrophy) 2

Prognostic Stratification Using Results

The absolute β-hCG value determines risk category and treatment intensity:

• Good prognosis (S1): β-hCG <5,000 IU/L 3
• Intermediate prognosis (S2): β-hCG 5,000–50,000 IU/L 3
• Poor prognosis (S3): β-hCG >50,000 IU/L 3

When Markers Alone May Suffice for Diagnosis

In rare medically unstable patients with life-threatening metastatic disease and a testicular, retroperitoneal, or anterior mediastinal mass, substantially elevated β-hCG and/or AFP may be considered sufficient for germ cell tumor diagnosis, and chemotherapy should not be delayed for tissue confirmation. 1, 4, 3